Cumberland Pharmaceuticals Inc. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
Cumberland Pharmaceuticals Inc. (CPIX) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2022-03-11
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-12-31 was $0.00.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2018-12-31 was $0.00.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2018-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2021 was $0.00.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2019 was $148.00K.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2018 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $148.00K 10-K · filed 2022-03-11 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $148.00K 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $148.00K 10-Q · filed 2019-08-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 | |||
| 2017-12-31 | $0.00 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |